Healthcare Chatbots Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

Healthcare Chatbots Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5000 – $10000

The overall healthcare chatbots market is projected to reach USD 381.3 million by 2030 from USD 127.0 million by 2020, at a CAGR of 21.8% during the forecast period.

SKU: FPG0301 Category: Tags: , , ,

Description

Healthcare Chatbots Market by Component (Software, Service), Deployment Model (Cloud, On-Premise), Application (Symptom Check, Medical Assistance, Appointment Booking), End User (Patient, Healthcare Providers, Insurance Companies) – Global Forecast to 2030
Product Overview
Chatbots is a software responsible for establishment of conversation between a human and artificial intelligence. Chatbots use textual or audio outputs to communicate with the customer. The conversation is carried out by using pre-calculated phrases in the form of texts. These chatbots are either cloud-based or on premise solutions, which are used by patients for checking symptoms, locating clinics or scheduling appointments. Furthermore, healthcare chatbots are also used by healthcare payers to establish a relation between the company and the potential customers.
Market Highlights
The overall healthcare chatbots market is projected to reach USD 381.3 million by 2030 from USD 127.0 million by 2020, at a CAGR of 21.8% during the forecast period. At present, chatbots are adopted among the developed countries such as North and Europe, and is yet to witness widespread adoption in emerging countries, where doctors and other healthcare providers are still reluctant to adopt advanced healthcare solutions.
Market Segmentations
Based on deployment, the cloud based segment occupied the largest share and is also the fastest growing segment during the forecast period owing to various advantages offered by these type of chatbots. For instance, cloud-based chatbots require less initial investment, they are more accessible and require less customization as compared to on premise based chatbots. Therefore, factors aforementioned contribute to healthcare chatbots market growth.
Market Dynamics
Optimum internet connectivity and rising adoption of smart devices will favor the growth of the healthcare chatbot solutions market
Rising internet connectivity and the growing adoption of smartphones and mobile platforms play a key role in ensuring the adoption and use of chatbots. This has ensured growing number of consumers to access healthcare services, and also greatly broadened the reach of said services. According to data published by Anthem Insurance Companies, Inc. (U.S.) in May 2017, approximately 50% of smartphone users gather health information using mobile apps; 36% of doctors say apps are the most effective way to engage with patients; and 90% of doctors believe mobile apps can improve health.
Technology advancement in artificial intelligence drives the healthcare chatbots market growth
Widespread advancements occurring in the field of artificial intelligence is primarily responsible for driving growth in the global healthcare chatbots market. This is mainly due to the implementation of more sophisticated and mature chatbot processes that are intensely smart to deal with engaging customers who intend to access healthcare services.
Regions
North America accounted for the major healthcare chatbots market share in 2018 and is expected to continue this trend owing to, easy availability of the healthcare chatbots service. Moreover, the long patient waiting time contribute to the growth of global healthcare chatbots market in North America. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period owing to surge in awareness related to the use of healthcare chatbots. The constantly evolving life science industry drives the growth of the market in the developing economies such as India, China, Malaysia, and others.
Key Players
• ealthTap, Inc.,
• Anboto
• Sensely
• Buoy Health, Inc.
• Infermedica
• Babylon
• Baidu, Inc.
• Ada Health GmbH
• PACT Care BV
• Woebot
• GYANT.COM, Inc.
• Creative Virtual
• Your.MD
• Synthetix Ltd.
• Next IT Corp.
• CX Company

Healthcare Chatbots Market Segments:
By Application
• Symptoms Check
• Medical & Drug Information Assistance
• Appointment Scheduling & Monitoring
• Other Applications
By Deployment
• Cloud-based
• On-premise
By End User
• Healthcare Providers
• Healthcare Payers
• Patients
• Other End Users

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents 1. Executive Summary 2. Global Healthcare Chatbots Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Global Healthcare Chatbots Market Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Global Healthcare Chatbots Market 11.1. Market Size & forecast, 2020A-2030F 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12. Global Healthcare Chatbots Market: Market Segmentation 12.1. By Regions 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2. By Application: Market Share (2020-2030); 12.2.1. Symptoms Check, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.2. Medical & Drug Information Assistance, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.3. Appointment Scheduling & Monitoring, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.4. Other, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3. By Deployment: Market Share (2020-2030F) 12.3.1. Cloud-based, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3.2. On-premise, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4. By End user: Market Share (2020-2030F) 12.4.1. Healthcare Providers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.2. Healthcare Payers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.3. Patients, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 13 Company Profile 13.1. HealthTap, Inc. 13.1.1. Company Overview 13.1.2. Company Total Revenue (Financials) 13.1.3. Market Potential 13.1.4. Global Presence 13.1.5. Key Performance Indicators 13.1.6. SWOT Analysis 13.1.7. Product Launch 13.2. Anboto 13.3. Sensely 13.4. Buoy Health, Inc. 13.5. Infermedica 13.6. Babylon 13.7. Baidu, Inc. 13.8. Ada Health GmbH 13.9. PACT Care BV 13.10. Woebot 13.11. GYANT.COM, Inc. 13.12. Creative Virtual 13.13. Other Prominent Players 14 Consultant Recommendation **The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Related products